Find the products and resources you are looking for!
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Human peripheral blood mononuclear cells (PBMCs) were either left unstimulated (left image) or stimulated with 20 ng/mL Phorbol 12-myristate 13-acetate (PMA) and 1 µg/mL ionomycin for 6 hours, followed by an incubation with 1 µg/mL brefeldin A after 2 hours at 37 °C. Cells were fixed, permeabilized, and stained with Anti-IL-2 antibodies as well as with CD69 antibodies. Flow cytometry was performed using the MACSQuant®
Analyzer. Cell debris were excluded from the analysis based on scatter signals.
In order to compare the epitope specificity of REAfinity Clone REA689 with other known clones, a competition assay was performed.
Cells were incubated with an excess of purified unconjugated REAfinity Antibody followed by staining with fluorochrome-conjugated antibodies of other known clones against the same marker. Based on the fluorescence signal obtained, the clones were identified as recognizing completely overlapping (++), partially overlapping (+), or completely different epitopes (-) of the marker.
|Other clones||Overlap in epitope recognition with REA689|
Copyright © 2019 Miltenyi Biotec and/or its affiliates. All rights reserved.